marginally significantp = 0.05
Among them, NTN1 exhibited a marginally significant difference across DLBCL clinical stages (Kruskal-Wallis test, p = 0.05), suggesting a potential association with disease progression.
Among them, NTN1 exhibited a marginally significant difference across DLBCL clinical stages (Kruskal-Wallis test, p = 0.05), suggesting a potential association with disease progression.